A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group-Comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode.

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group-Comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 May 2016

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Acronyms AMAZE
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 30 Apr 2012 Results published in the World Journal of Biological Psychiatry.
    • 30 Apr 2012 Primary endpoint 'Young-Mania-Rating-Scale' has been met according to results published in the World Journal of Biological Psychiatry.
    • 11 Jul 2011 Planned end date changed from 1 Dec 2009 to 1 Nov 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top